STERIS Net Profit Margin 2010-2022 | STE
Current and historical net profit margin for STERIS (STE) from 2010 to 2022. Net profit margin can be defined as net Income as a portion of total sales revenue. STERIS net profit margin for the three months ending March 31, 2022 was .
| STERIS Net Profit Margin Historical Data |
| Date |
TTM Revenue |
TTM Net Income |
Net Margin |
| 2022-03-31 |
$4.59B |
$0.24B |
5.32% |
| 2021-12-31 |
$4.25B |
$0.28B |
6.57% |
| 2021-09-30 |
$3.85B |
$0.25B |
6.50% |
| 2021-06-30 |
$3.41B |
$0.29B |
8.39% |
| 2021-03-31 |
$3.11B |
$0.40B |
12.81% |
| 2020-12-31 |
$3.06B |
$0.43B |
14.20% |
| 2020-09-30 |
$3.02B |
$0.42B |
14.03% |
| 2020-06-30 |
$3.00B |
$0.41B |
13.75% |
| 2020-03-31 |
$3.03B |
$0.41B |
13.46% |
| 2019-12-31 |
$2.98B |
$0.39B |
13.21% |
| 2019-09-30 |
$2.90B |
$0.34B |
11.59% |
| 2019-06-30 |
$2.84B |
$0.32B |
11.20% |
| 2019-03-31 |
$2.78B |
$0.30B |
10.89% |
| 2018-12-31 |
$2.73B |
$0.27B |
9.85% |
| 2018-09-30 |
$2.70B |
$0.32B |
11.72% |
| 2018-06-30 |
$2.65B |
$0.30B |
11.43% |
| 2018-03-31 |
$2.62B |
$0.29B |
11.11% |
| 2017-12-31 |
$2.59B |
$0.24B |
9.40% |
| 2017-09-30 |
$2.57B |
$0.14B |
5.56% |
| 2017-06-30 |
$2.58B |
$0.12B |
4.61% |
| 2017-03-31 |
$2.61B |
$0.11B |
4.17% |
| 2016-12-31 |
$2.62B |
$0.14B |
5.38% |
| 2016-09-30 |
$2.59B |
$0.17B |
6.40% |
| 2016-06-30 |
$2.44B |
$0.14B |
5.54% |
| 2016-03-31 |
$2.24B |
$0.11B |
4.96% |
| 2015-12-31 |
$2.05B |
$0.09B |
4.58% |
| 2015-09-30 |
$1.91B |
$0.11B |
5.88% |
| 2015-06-30 |
$1.88B |
$0.13B |
7.14% |
| 2015-03-31 |
$1.85B |
$0.14B |
7.29% |
| 2014-12-31 |
$1.81B |
$0.13B |
7.33% |
| 2014-09-30 |
$1.75B |
$0.12B |
7.10% |
| 2014-06-30 |
$1.67B |
$0.12B |
7.37% |
| 2014-03-31 |
$1.62B |
$0.13B |
8.01% |
| 2013-12-31 |
$1.59B |
$0.13B |
8.32% |
| 2013-09-30 |
$1.56B |
$0.15B |
9.68% |
| 2013-06-30 |
$1.53B |
$0.16B |
10.51% |
| 2013-03-31 |
$1.50B |
$0.16B |
10.59% |
| 2012-12-31 |
$1.46B |
$0.16B |
11.07% |
| 2012-09-30 |
$1.44B |
$0.15B |
10.29% |
| 2012-06-30 |
$1.43B |
$0.14B |
9.68% |
| 2012-03-31 |
$1.41B |
$0.14B |
9.74% |
| 2011-12-31 |
$1.40B |
$0.13B |
9.46% |
| 2011-09-30 |
$1.37B |
$0.12B |
8.77% |
| 2011-06-30 |
$1.34B |
$0.13B |
9.42% |
| 2011-03-31 |
$1.21B |
$0.05B |
4.31% |
| 2010-12-31 |
$1.16B |
$0.04B |
3.70% |
| 2010-09-30 |
$1.16B |
$0.06B |
5.34% |
| 2010-06-30 |
$1.16B |
$0.06B |
4.99% |
| 2010-03-31 |
$1.26B |
$0.13B |
10.25% |
| 2009-12-31 |
$1.27B |
$0.13B |
10.00% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical Instruments Manufacturing |
$21.113B |
$4.585B |
|
STERIS plc, develops, manufactures and markets infection prevention, decontamination, microbial reduction, and surgical and gastrointestinal support products and services. On Nov 2, 2015, STERIS completed the acquisition of Synergy Health plc following which it was re-registered under the name ' STERIS plc. Currently, STERIS serves healthcare, pharmaceutical, research, industrial and governmental customers across the globe. The majority of STERIS' revenues is derived from the healthcare and pharmaceutical industries. STERIS provides its products and services in more than 60 countries. The company's key areas of strategic focus include developing its customer base in Europe, the Middle East and the Asia Pacific region.
|
